PMC:7534795 / 20151-20415 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T24819","span":{"begin":7,"end":12},"obj":"Body_part"},{"id":"T11221","span":{"begin":71,"end":79},"obj":"Body_part"}],"attributes":[{"id":"A40022","pred":"fma_id","subj":"T24819","obj":"http://purl.org/sig/ont/fma/fma67498"},{"id":"A30272","pred":"fma_id","subj":"T11221","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":" multi-organ damage (ChiCTR2000029765, 2020)\n• Tocilizumab to mitigate cytokine storm and associated complications • Retrospective cohort study\n• \u003e18 years of age\n• Intensive care unit (ICU) COVID-19 hospitalization\n• Primary endpoint of hospital-related mortality"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T40","span":{"begin":7,"end":12},"obj":"Body_part"}],"attributes":[{"id":"A40","pred":"uberon_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":" multi-organ damage (ChiCTR2000029765, 2020)\n• Tocilizumab to mitigate cytokine storm and associated complications • Retrospective cohort study\n• \u003e18 years of age\n• Intensive care unit (ICU) COVID-19 hospitalization\n• Primary endpoint of hospital-related mortality"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T182","span":{"begin":191,"end":199},"obj":"Disease"}],"attributes":[{"id":"A182","pred":"mondo_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" multi-organ damage (ChiCTR2000029765, 2020)\n• Tocilizumab to mitigate cytokine storm and associated complications • Retrospective cohort study\n• \u003e18 years of age\n• Intensive care unit (ICU) COVID-19 hospitalization\n• Primary endpoint of hospital-related mortality"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T90672","span":{"begin":7,"end":12},"obj":"http://purl.obolibrary.org/obo/UBERON_0003103"},{"id":"T42818","span":{"begin":147,"end":149},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":" multi-organ damage (ChiCTR2000029765, 2020)\n• Tocilizumab to mitigate cytokine storm and associated complications • Retrospective cohort study\n• \u003e18 years of age\n• Intensive care unit (ICU) COVID-19 hospitalization\n• Primary endpoint of hospital-related mortality"}

{"project":"LitCovid-sentences","denotations":[{"id":"T126","span":{"begin":45,"end":143},"obj":"Sentence"},{"id":"T127","span":{"begin":144,"end":162},"obj":"Sentence"},{"id":"T128","span":{"begin":163,"end":215},"obj":"Sentence"},{"id":"T129","span":{"begin":216,"end":264},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" multi-organ damage (ChiCTR2000029765, 2020)\n• Tocilizumab to mitigate cytokine storm and associated complications • Retrospective cohort study\n• \u003e18 years of age\n• Intensive care unit (ICU) COVID-19 hospitalization\n• Primary endpoint of hospital-related mortality"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T87","span":{"begin":71,"end":85},"obj":"Phenotype"}],"attributes":[{"id":"A87","pred":"hp_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":" multi-organ damage (ChiCTR2000029765, 2020)\n• Tocilizumab to mitigate cytokine storm and associated complications • Retrospective cohort study\n• \u003e18 years of age\n• Intensive care unit (ICU) COVID-19 hospitalization\n• Primary endpoint of hospital-related mortality"}

{"project":"LitCovid-PubTator","denotations":[{"id":"683","span":{"begin":1,"end":58},"obj":"Disease"},{"id":"684","span":{"begin":191,"end":199},"obj":"Disease"}],"attributes":[{"id":"A683","pred":"tao:has_database_id","subj":"683","obj":"MESH:C564969"},{"id":"A684","pred":"tao:has_database_id","subj":"684","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" multi-organ damage (ChiCTR2000029765, 2020)\n• Tocilizumab to mitigate cytokine storm and associated complications • Retrospective cohort study\n• \u003e18 years of age\n• Intensive care unit (ICU) COVID-19 hospitalization\n• Primary endpoint of hospital-related mortality"}